NASDAQ
NEO

NeoGenomics Inc

SERVICES-TESTING LABORATORIES
TRADE & SERVICES

Prices are adjusted according to historical splits.

NeoGenomics Inc Stock Price

Vitals

Today's Low:
$7.3100
Today's High:
$7.8500
Open Price:
$7.5900
52W Low:
$6
52W High:
$44.26
Prev. Close:
$7.6500
Volume:
1542709

Company Statistics

Market Cap.:
$0.923 billion
Book Value:
8.3
Revenue TTM:
$0.489 billion
Operating Margin TTM:
-34.1%
Gross Profit TTM:
$0.192 billion
Gross Profit TTM:
$0.192 billion
Profit Margin:
-30%
Return on Assets TTM:
-5.65%
Return on Equity TTM:
-13.4%

Company Profile

NeoGenomics Inc had its IPO on 2004-03-16 under the ticker symbol NEO.

The company operates in the TRADE & SERVICES sector and SERVICES-TESTING LABORATORIES industry. NeoGenomics Inc has a staff strength of 0 employees.

Stock update

Shares of NeoGenomics Inc opened at $7.59 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $7.31 - $7.85, and closed at $7.34.

This is a -4.05% slip from the previous day's closing price.

A total volume of 1,542,709 shares were traded at the close of the day’s session.

In the last one week, shares of NeoGenomics Inc have slipped by -8.25%.

NeoGenomics Inc's Key Ratios

NeoGenomics Inc has a market cap of $0.923 billion, indicating a price to book ratio of 0.903 and a price to sales ratio of 1.887.

In the last 12-months NeoGenomics Inc’s revenue was $0.489 billion with a gross profit of $0.192 billion and an EBITDA of $-0.106 billion. The EBITDA ratio measures NeoGenomics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, NeoGenomics Inc’s operating margin was -34.1% while its return on assets stood at -5.65% with a return of equity of -13.4%.

In Q2, NeoGenomics Inc’s quarterly earnings growth was a positive 130.6% while revenue growth was a positive 2.8%.

NeoGenomics Inc’s PE and PEG Ratio

Forward PE
222.22
Trailing PE
-
PEG
3.02

Its diluted EPS in the last 12-months stands at $-0.294 per share while it has a forward price to earnings multiple of 222.22 and a PEG multiple of 3.02. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NeoGenomics Inc’s profitability.

NeoGenomics Inc stock is trading at a EV to sales ratio of 2.224 and a EV to EBITDA ratio of 343.81. Its price to sales ratio in the trailing 12-months stood at 1.887.

NeoGenomics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

NeoGenomics Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

NeoGenomics Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

NeoGenomics Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, NeoGenomics Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, NeoGenomics Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$7.34
52-Week High
$44.26
52-Week Low
$6
Analyst Target Price
$16.78

NeoGenomics Inc stock is currently trading at $7.34 per share. It touched a 52-week high of $44.26 and a 52-week low of $44.26. Analysts tracking the stock have a 12-month average target price of $16.78.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About NeoGenomics Inc

The stock symbol (also called stock or share ticker) of NeoGenomics Inc is NEO

The IPO of NeoGenomics Inc took place on 2004-03-16

Similar Industry Stocks (SERVICES-TESTING LABORATORIES)

Last Price
Chg
Chg%
TrueBlue Inc (TBI)
$19.5
-0.2
-1.02%
Invitae Corp (NVTA)
$2.69
-0.17
-5.94%
$94
-4.36
-4.43%
$349.79
1.21
+0.35%
$38.55
-0.59
-1.51%
$107.58
-6.09
-5.36%
$165.31
-2.29
-1.37%
$1.26
-0.14
-10%
Precipio Inc (PRPO)
$0.82
-0.03
-3.24%
Pro-Dex Inc (PDEX)
$18.8
-0.08
-0.42%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.

Address

12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS, FL, US